Large-scale testing (Phase 3)Active Not RecruitingNCT03595592
What this trial is testing
Neoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast Cancer
Who this might be right for
Invasive Breast Cancer
Fondazione Michelangelo 650